MyFinsight
Home
Blog
About
Contact
Download
Download image
Net gain
-$21,299K
(-295.08%↓ Y/Y)
Segment net loss
-$21,299K
Interest income
$535K
(-31.06%↓ Y/Y)
Ipr&d expense
$8,000K
Other segment expense
(income)
-$6,429K
Selling, general and
administrative
$4,588K
(23.13%↑ Y/Y)
Clinical expense
$2,015K
Chemistry, manufacturing,
and controls
$555K
Preclinical expense
$247K
Back
Back
Income Statement
source: myfinsight.com
SCYNEXIS INC (SCYX)
SCYNEXIS INC (SCYX)